STRATA Skin Sciences, Inc. (OTC: SSKN)

STRATA Skin Sciences, Inc. is a medical technology company that develops, commercializes and markets innovative products for the treatment of dermatologic conditions.

Its product portfolio includes the XTRAC excimer laser systems, the VTRAC lamp systems and the TheraClear acne therapy system.

The company generates revenue primarily through a dermatology recurring procedures model in the United States where it places XTRAC laser systems in physician offices at no upfront charge and earns fees based on each treatment performed.

Internationally it sells XTRAC and VTRAC equipment through direct distribution agreements with distributors and also offers the TheraClear system for sale, generating revenue from product sales and related service support.

The company operates through the following segments.

• Dermatology Recurring Procedures segment involves placing XTRAC excimer laser systems in dermatology practices across the United States under a no up front charge arrangement and receiving payment for each treatment delivered.

• Dermatology Procedures Equipment segment comprises the sale of XTRAC and VTRAC laser and lamp systems to customers outside the United States through direct distributor agreements and includes related installation training and after sales service.

STRATA Skin Sciences, Inc. holds a niche position in the dermatology phototherapy market where its XTRAC excimer laser systems are recognized for strong clinical efficacy minimal side effects and reimbursement support from major insurers including Medicare. Key competitors include The Daavlin Company National Biologic Corporation and various pharmaceutical firms that offer topical or systemic therapies for psoriasis vitiligo and acne. The company’s competitive advantages stem from its FDA cleared technology broad insurance coverage established relationships with dermatology providers and a recurring revenue model that provides predictable cash flow.

Domestically the company serves dermatologists and dermatology group clinics that participate in its recurring procedures model with 842 active partner clinics across the United States as of the end of 2025. Internationally it works with distributors in countries such as Korea Japan China Israel Saudi Arabia Kuwait Oman Qatar Bahrain UAE Jordan Iraq Mexico and India to sell equipment and generate recurring revenue on a country by country basis.